Skip to content

Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Pilot Trial)

Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Pilot Phase)

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02109198
Enrollment
0
Registered
2014-04-09
Start date
2015-06-30
Completion date
2016-08-31
Last updated
2015-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Traumatic Brain Injury

Keywords

Mild Traumatic Brain Injury

Brief summary

The purpose of this study is to determine the feasibility of combining PoNS therapy with standard vestibular and balance therapy with the proposed double-blind design; evaluate preliminary indications of efficacy. This study is also evaluating recruitment rate, completion rate, device usability, and outcome measures feasibility. * Goal for recruitment: 100% of 30 subjects meeting all inclusion criteria can be recruited over the 36 week pilot recruitment phase. * Completion and compliance: 90% of subjects will complete the study, 90% of sessions within each subject will be completed, and for completing subjects, 100% of measures will be completed. * Useability: all therapists and subjects must rate useability as good or better. * Success of blind: subject accuracy at guessing group membership must be at or near 50%.

Interventions

Delivery of active stimulation of the tongue during in-person therapy sessions (1 hour) and during two home sessions (40 minutes) daily on 6 of 7 days per week (120 total sessions). Stimulation sessions will be separated by at least 4 hours.

Delivery of sham stimulation of the tongue during in-person therapy sessions (1 hour) and during two home sessions (40 minutes) daily on 6 of 7 days per week (120 total sessions). Stimulation sessions will be separated by at least 4 hours.

Sponsors

Virginia Commonwealth University
CollaboratorOTHER
US Department of Veterans Affairs
CollaboratorFED
The Defense and Veterans Brain Injury Center
CollaboratorFED
U.S. Army Medical Research and Development Command
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Veteran or Servicemember 2. 18 to 50 years old 3. Sustained one or more mild traumatic brain injury (mTBI)s 4. Demonstration of balance deficits on the Sensory Organization Test (a composite score of 75 or less (1/3 sample) and 72 or less (2/3 sample)) 5. Available for the duration of the study

Exclusion criteria

1. History of traumatic brain injury (TBI) of any severity other than mild TBI 2. Presence of active substance abuse condition 3. Any condition for which posturography is contraindicated (e.g. leg amputation or fracture) 4. Diagnosed neurological disorder with balance sequelae, other than TBI (e.g. Parkinson's disease, incomplete spinal cord injury, or Multiple Sclerosis) 5. Orthostatic hypotension as defined by: 1. A systolic blood pressure decrease (from supine to sitting) of at least 20 mmHg 2. A diastolic blood pressure decrease of at least 10 mmHg, or 3. A pulse increase of 30 beats or more per minute with associated signs or symptoms of cerebral hypoperfusion 6. An implanted medical device 7. Pregnancy 8. Oral infection 9. Known transmissible disease (HIV, hepatitis, influenza, TB) 10. Exam signs of serious disorder other than mTBI as defined by facial asymmetry, hoarseness and dysarthria (e.g. tumor, stroke).

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rate36 weeksNumber and percentage of subjects recruited over the 36 week pilot recruitment phase
Completion and compliance ratesUp to 12 weeksNumber and percentage of subjects who complete the study
Usability rating12 weeksNumber and percentage of subjects and therapists who rated usability as good or better.
Success of blinding12 weeksNumber and percentage of subjects who accurately guess group membership
Change in Sensory Organization Test (SOT)12 weeksComparison of the SOT score between the treatment group and sham group at the intermediate follow-up.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026